Furthermore, no gene was predominant as seen for gene/cancer combinations such as BRCA1 and BRCA2 in breast and ovarian cancer, CDKN2A in melanoma, or MLH1 and MSH2 in Lynch syndrome [49, 54, 55]. This evidence concerns the gene MLH1 and Lynch syndrome.